Global Health Briefs: Nigeria Receives mpox Vaccine, Mundipharma Sale Falters, Biden's Drug Cap and More

The key highlights in current health news include Nigeria's receipt of mpox vaccine doses from USAID, Fitch's warning on fiscal pressures from mpox in sub-Saharan Africa, Mundipharma's failed China unit sale, Biden's drug cap savings for U.S. seniors, a CDC warning on stress in parents, and a Listeria outbreak linked to deli meats.

The latest updates in global health include Nigeria receiving 10,000 doses of the mpox vaccine from USAID, as announced by Muyi Aina of NPHCDA, marking a significant step in the fight against the virus, which has seen 40 reported cases in the country so far.

Fitch Ratings has issued a warning that the rapid spread of mpox in sub-Saharan Africa risks worsening fiscal pressures in the already financially strained region. The WHO recently declared mpox, especially the new clade Ib strain, a global health emergency.

Mundipharma International's attempts to sell its China unit have failed for the second time this year, insiders say. The company, owned by the Sackler family and known for OxyContin, sought over $1 billion in the sale managed by Deutsche Bank.

In a favorable development for U.S. seniors, a study reveals that President Biden's upcoming cap on prescription drug costs could save more than 1 million people over $1,000 annually. This cap is part of the Medicare Part D program under Biden's Inflation Reduction Act.

U.S. Surgeon General Vivek Murthy has raised alarms over the mental health crisis among parents due to modern stresses, urging a collaborative approach from government, businesses, and community groups to enhance support systems.

The CDC reports that a Listeria outbreak tied to deli meats has resulted in 14 new cases and five more deaths. The outbreak now totals 57 cases and eight fatalities.

(With inputs from agencies.)